AABB is organized, led and governed in a manner that permits rapid, thoughtful and effective policymaking. Consistent with its commitment to the highest standards of care for patients and donors, the association closely adheres to operating principles and practices that promote ethics and transparency. The Sarbanes-Oxley Act was adopted primarily to restore confidence in publicly traded entities, but AABB has joined other not-for-profit organizations in embracing sections of the act that help ensure accountability and compliance. AABB diligently works to identify and incorporate best practices that help mitigate risk and improve processes.

This section includes some of the guidelines and policies that have been developed to help ensure accountability and compliance, as well as members-only content relating to the organization's volunteer leadership, including board members profiles, descriptions of AABB committees, and association election information.  

AABB Code of Ethics (PDF)
AABB Bylaws (PDF)
AABB Firewall Policy (PDF)
AABB Policy on Conflicts of Interest and Confidentiality (PDF)
AABB Trademark Usage Guidelines (PDF)

2016 – 2017 AABB Board of Directors

Zbigniew M. Szczepiorkowski, MD, PhD, FCAP – Dartmouth-Hitchcock Hospital Center – Geisel School of Medicine at Dartmouth – President
Donna M. Regan, MT(ASCP)SBB – SSM Cardinal Glennon Children's Hospital – Past President
Mary Beth Bassett, BS, MT(ASCP) – Blood Systems, Inc. – President-Elect
Michael F. Murphy, MD, FRCP, FRCPath, FFPath – National Blood Service Blood and Transplant – Radcliffe Oxford University Hospital – Vice President
Susan Roseff, MD – Virginia Commonwealth University Medical Center - Secretary
Donald Berglund, MHA, FACHE – Innovative Blood Resources – Treasurer
Julie Allickson, PhD, MS, MT(ASCP) - Institute For Regenerative Medicine
Barbara Bryant, MD - University of Texas Medical Branch
Dana Devine, PhD - Canadian Blood Services
Steven Frank, MD – Johns Hopkins University School of Medicine
David Green, MSA - Blood Systems (BSI)
Richard Kaufman, MD - Brigham & Women's Hospital
Debra Kessler, RN, MS – New York Blood Center
Steven Sloan, MD, PhD – Boston Children's Hospital
Steven Spitalnik, MD - Columbia University
David Stroncek, MD – National Institutes of Health
Aaron Tobian, MD - Johns Hopkins Hospital
Dan Waxman, MD - Indiana Blood Center
Jim Zimring, MD, PhD - BloodworksNW Research Institute
Thomas Hopkins – AABB - Interim CEO

Contact executive@aabb.org.